CAV1 and Parkinson disease: Interestingly, overexpression of α-synuclein, a PD-associated gene product, also upregulates cav-1 expression, which mediates α-synuclein neurotoxicity [55, 56], supporting the involvement of the dysregulation of cav-1 in the pathogenesis of PD.